In The News Posted February 5, 2019 Share Posted February 5, 2019 WASHINGTON, Feb. 5, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) has filed a complaint against the U.S. Food and Drug Administration (the FDA) requesting that the court lift a partial clinical hold the agency illegally imposed prohibiting Vanda from studying a promising new... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.